Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 20.88 USD 2.5% Market Closed
Market Cap: 1.8B USD

Wall Street
Price Targets

SNDX Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast SNDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNDX is 40.09 USD with a low forecast of 27.27 USD and a high forecast of 58.8 USD.

Lowest
Price Target
27.27 USD
31% Upside
Average
Price Target
40.09 USD
92% Upside
Highest
Price Target
58.8 USD
182% Upside
Syndax Pharmaceuticals Inc Competitors:
Price Targets
VLA
Valneva SE
99% Upside
MRUS
Merus NV
3% Upside
NRIX
Nurix Therapeutics Inc
46% Upside
302440
SK Bioscience Co Ltd
24% Downside
EDT
Spectral Medical Inc
147% Upside
PHIL
Philogen SpA
13% Upside
ABOS
Acumen Pharmaceuticals Inc
222% Upside
CANTA
Cantargia AB
101% Upside

Revenue
Forecast

Revenue Estimate
Syndax Pharmaceuticals Inc

The compound annual growth rate of Syndax Pharmaceuticals Inc's revenue for the next 4 years is 138%.

N/A
Past Growth
138%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNDX's stock price target?
Price Target
40.09 USD

According to Wall Street analysts, the average 1-year price target for SNDX is 40.09 USD with a low forecast of 27.27 USD and a high forecast of 58.8 USD.

What is Syndax Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
138%

The compound annual growth rate of Syndax Pharmaceuticals Inc's revenue for the next 4 years is 138%.

Back to Top